Livzon Pharmaceutical Group Inc. (SHE:000513)
30.47
+0.59 (1.97%)
Jun 9, 2026, 3:04 PM CST
SHE:000513 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHE:000513 stock has a consensus rating of "Buy" and an average price target of ¥39.28. The average 1-year stock price forecast is 28.91% higher than the current stock price, while the lowest is ¥25.52 (-16.25%) and the highest is ¥47.60 (+56.22%).
Price Target: ¥39.28 (+28.91%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:000513 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
11.88B
from 12.02B
Decreased by -1.16%
Revenue Next Year
12.87B
from 11.88B
Increased by 8.29%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.2B | ||
| Avg | 11.9B | ||
| Low | 11.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5% | ||
| Avg | -1.2% | ||
| Low | -3.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |